# Dexmedetomidine or Hyalase : Which of Them Can Augment Lumbar Epidural Steroid Injection in Failed Back Surgery Patients. A Randomized Clinical Trial

> **NCT05370963** · EARLY_PHASE1 · COMPLETED · sponsor: **Minia University** · enrollment: 100 (actual)

## Conditions studied

- Pain, Chronic

## Interventions

- **DRUG:** Hylase versus dexmedtemodine

## Key facts

- **NCT ID:** NCT05370963
- **Lead sponsor:** Minia University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-20
- **Primary completion:** 2023-05-30
- **Final completion:** 2023-06-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2024-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05370963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05370963, "Dexmedetomidine or Hyalase : Which of Them Can Augment Lumbar Epidural Steroid Injection in Failed Back Surgery Patients. A Randomized Clinical Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05370963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*